CRAYON
13.10.2020 08:02:04 CEST | Business Wire | Press release
Crayon , a global leader in digital transformation, today announced it is expanding its partnership with Workplace from Facebook to change the way organizations communicate and get work done. Crayon has offered Workplace , a business collaboration tool, in the Nordics since 2018 and this new agreement will expand the partnership into 20 more countries over the next year.
Crayon has seen an increase in the need for collaborative tools as companies around the world shifted to a new approach to work, connecting a more remote and distributed workforce. The expanded partnership means Crayon and Workplace will help organizations work closer together, break down communication silos and enable stronger company culture, especially with remote and frontline workers by providing a unified system of engagement and collaboration.
“This partnership means we can help more companies to connect on one platform so that everyone feels like they have a voice in the organization,” said Crayon co-founder Rune Syversen. “We understand the challenge of the connected company has nothing to do with technology, it has to do with changing the culture toward open collaboration. Our Workplace program is about just that – helping our customers to leverage the benefits of the Workplace platform emphasizing cultural changes. Since we started this partnership, we’ve observed Workplace becoming our fastest growing tech partner, particularly as the technology works well with the Microsoft IT stack. For us, along with Workplace, it’s not just another IT implementation, it is an introduction of a whole new way of communicating across the entire company.”
Crayon has helped deploy Workplace at all types of organizations, from healthcare companies to transportation organizations globally.
“Our employees have different workspaces, some are working from their office, others are working from a farm. We needed a way to communicate with everyone across the organization regardless of where or how they did their job and Workplace made that possible,” said Meylin S. Loo, Digital Communications Chief for Tine in Norway.
“Also, for us it was important to have a partner that had implemented this solution before to give us crucial guidance on best practices. Plus, we already have a long-standing successful relationship with Crayon and so we knew they were the right one to help us implement Workplace.”
Among the 20 countries that Crayon and Workplace will expand to include Norway, Denmark, Sweden, Finland, the UK, France and the US.
“We are proud to expand our partnership with Crayon, which has dozens of joint Workplace customers and has added their technical expertise to each launch to enable wall-to-wall adoption of Workplace across every employee in an organization. This deepened partnership and new growth trajectory is another important milestone on our two companies’ journeys. Right now companies around the world are trying to keep their workforces connected, engaged and keep their employees informed, and we believe that Workplace is a perfect solution for many of today’s real-world challenges,” said Julien Codorniou, VP, Workplace from Facebook.
About Crayon:
Crayon helps customers build the commercial and technical foundation for a successful digital transformation journey through a reliable services framework allowing our customers to right-size and optimize their IT estates. Headquartered in Oslo, Norway, Crayon has over 1600 employees across more than 50 locations worldwide.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201012005539/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
